Western Medicine
Phase 3Small molecule
Western Medicine is one of 126 small molecule programs targeting Obstructive Sleep Apnea. It is currently in Phase 3.
3
Indications
6
Total Trials
3
Active Trials
125
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
143 competitors in Osteoarthritis
#DrugCompanyPhaseTrials
1Western Medicine
PPeking Union Medical College Hospital
Phase 3
Toradol
RochePreclinical
Cataflam
NovartisPreclinical
Bayer Aspirin
BayerPreclinical
Enbrel
IImmunex
Preclinical
Glucophage
EMD SeronoPreclinical
Precedex
MMcNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.
Preclinical
Protonix
WWyeth-Lederle Vaccines
Preclinical
Catapres
Boehringer IngelheimPreclinical
MS Contin
HHikma Pharmaceuticals LLC
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Burning Mouth Syndrome1 trial
Treatment of Burning Mouth Syndrome With Integration of Traditional Chinese Medicine and Western Medicine
Unknown status·—·Phase 3·NCT04189367·80 enrolled
Psoriasis1 trial
Infertility1 trial
Obstructive Sleep Apnea1 trial
Collaborative Care Model for Allergic Rhinitis With Obstructive Sleep Apnea From Prevention to Treatment.
Unknown status·—·N/A·NCT04621513·60 enrolled
Osteoarthritis1 trial
Integrative Chinese and Western Medicine for Knee Osteoarthritis
Not yet recruiting·—·N/A·NCT07072442·228 enrolled
1 more indication
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Western Medicine. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details